Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years old or older
- You must have been diagnosed with lung cancer, colon cancer, or Non-Hodgkin's lymphoma (a type of blood cancer)
- You must have finished your cancer treatment (such as chemotherapy, targeted therapy, or immunotherapy) at least six months ago — or you have cancer that has spread but you are not currently receiving any cancer treatment
- You must be able to provide a saliva sample
- You must be willing to give your consent to take part and agree to be randomly placed into a group as part of the study
- You must be able to read and complete questionnaires written in English
Who may not be able to join:
- People whose primary cancer is anal cancer or rectal cancer cannot join
- People who are currently receiving active cancer treatment cannot join
- People who have mouth problems or any other condition that makes it difficult to produce saliva cannot join
- People who are unable to take part for the full length of the study, including any follow-up period afterwards, cannot join
- People who are pregnant or planning to become pregnant during the study cannot join
- People who currently practice yoga or a stress-reduction technique called SMART cannot join
- People who are currently taking steroid medications (corticosteroids) cannot join
- People who have had a fall or a fainting episode within the last six months cannot join
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Barbara Nemesure, PhD, Stony Brook University
Phone: 631-728-7425
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient Reported Quality of Life (QOL) by EORTC QLQ-C30; Patient Reported Quality of Life (QOL) by EORTC QLQ-SURV100; Patient Reported Quality of Life (QOL) by QLQ-ANL27; Patient Reported Quality of Life (QOL) by QLQ-BIL21; Patient Reported Quality of Life (QOL) by QLQ-BN20; Patient Reported Quality of Life (QOL) by QLQ-BR42; Patient Reported Quality of Life (QOL) by QLQ-CLL17; Patient Reported Quality of Life (QOL) by QLQ-CR29; Patient Reported Quality of Life (QOL) by QLQ-CX24; Patient Reported Quality of Life (QOL) by QLQ-EN24; Patient Reported Quality of Life (QOL) by QLQ-GINET21; Patient...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.